Core Nursing Explanation
Key Concept Analysis: This question assesses the priority nursing intervention for a patient starting treatment for
Pulmonary Tuberculosis (TB). The core theme is
patient safety and medication management during the initial phase of multi-drug therapy. The first-line drugs, especially
Isoniazid (INH) and
Rifampin (RIF), carry a significant risk of
hepatotoxicity (liver damage). The initial phase is critical for establishing safety monitoring and ensuring the patient understands the importance of adherence to the long, complex regimen to prevent treatment failure and drug resistance.
Answer Rationale:
Key Point! Option ① is correct because it addresses the two most critical aspects of initial TB treatment:
safety and
adherence. Monitoring for hepatotoxicity (e.g., jaundice, fatigue, nausea, dark urine, elevated liver enzymes) is a direct, life-threatening concern that requires immediate nursing vigilance. Concurrently, educating the patient about
Directly Observed Therapy (DOT) principles and the consequences of non-adherence (drug-resistant TB) is fundamental to successful treatment and public health.
Distractor Analysis:
Watch out for confusion! Option ②: Strict contact isolation (Airborne Precautions) is initiated but is
not required for 6 months. Isolation is typically discontinued after the patient is on effective therapy, has a clinical response, and has three consecutive negative sputum smears (often after 2-4 weeks). A 6-month duration is incorrect and not the highest priority.
Option ③: While adequate hydration is generally good practice, preventing kidney stones is not a primary concern with standard first-line TB therapy. This is more relevant for drugs like
Indinavir (an HIV medication) or certain sulfa drugs.
Option ④: Chest X-rays are used to monitor progress, but they are not scheduled monthly. They are typically done at baseline, after 2-3 months of therapy, and at the end of treatment. Monitoring for drug side effects and ensuring adherence take precedence over routine imaging.
Related Concepts: The cornerstone of TB treatment is multi-drug therapy (often RIPE: Rifampin, Isoniazid, Pyrazinamide, Ethambutol) to prevent resistance.
Directly Observed Therapy (DOT) is the standard of care to ensure adherence. Nurses must also assess for other side effects: Rifampin can cause orange bodily fluids; Ethambutol can cause optic neuritis (monitor red-green color discrimination); Pyrazinamide can cause hyperuricemia.
Concept Summary
| Concept | Key Points |
|---|
| First-Line TB Drugs | Rifampin (RIF), Isoniazid (INH), Pyrazinamide (PZA), Ethambutol (EMB). Risk of hepatotoxicity (INH, RIF, PZA). |
| Priority Intervention | 1. Monitor for hepatotoxicity (liver function). 2. Ensure medication adherence (DOT). |
| Infection Control | Airborne Precautions (N95 respirator) until non-infectious (sputum smear negative x3). |
| Patient Education | Complete full course (6-9 months), report side effects (jaundice, vision changes), avoid alcohol. |
Side-by-Side Comparison!
| Drug Side Effect | Key Monitoring | Nursing Action |
|---|
| Isoniazid (INH): Hepatotoxicity, Peripheral Neuropathy | Liver enzymes (AST/ALT), symptoms of jaundice. Numbness/tingling in hands/feet. | Administer Pyridoxine (Vitamin B6) to prevent neuropathy. Educate to avoid alcohol. |
| Ethambutol (EMB): Optic Neuritis | Visual acuity, red-green color discrimination. | Baseline eye exam. Instruct patient to report any vision changes immediately. |
| Rifampin (RIF): Hepatotoxicity, Orange Body Fluids | Liver enzymes. Urine, sweat, tears may turn orange. | Forewarn patient about orange discoloration. Monitor for drug interactions (induces liver enzymes). |
Anatomy, Physiology & Pharmacology Points
The liver metabolizes most anti-TB drugs. Hepatotoxicity occurs when drug metabolites cause inflammation and damage to hepatocytes, potentially leading to liver failure. Isoniazid is metabolized by acetylation; "slow acetylators" are at higher risk for toxicity. Rifampin induces cytochrome P450 enzymes, increasing the metabolism of many other drugs (e.g., oral contraceptives, warfarin), which is a critical patient education point.
Memory Tips
RIPE for TB drugs:
Rifampin,
Isoniazid,
Pyrazinamide,
Ethambutol.
HALT for Hepatotoxicity monitoring:
Hepatomegaly (liver enlargement),
Anorexia,
Lethargy/fatigue,
Tender liver/jaundice.
Priority =
SAFE ADHERENCE:
Safety (Liver) first, then
Adherence (DOT).
High-Frequency NCLEX Topics
TB is a high-yield topic. NCLEX loves to test: 1)
Airborne Precautions (N95 respirator, negative pressure room), 2)
Key Point! Priority of monitoring for
hepatotoxicity, 3) Patient education on
medication adherence and DOT, 4) Differentiating side effects of specific drugs (vision vs. liver).
Watch Out for Question Variations!
* Instead of "highest priority," the question may ask: "The nurse should include which instruction in the teaching plan?" (Answer: Report yellowing of skin or eyes).
* The scenario may change to a patient developing symptoms: "A patient on INH reports fatigue and dark urine. What is the nurse's priority action?" (Answer: Hold the medication and notify the provider).
* It may test on infection control: "How long should a patient with pulmonary TB be in isolation?" (Answer: Until on effective therapy and sputum smears are negative x3).